Stockreport

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043 [Yahoo! Finance]

Surrozen, Inc.  (SRZN) 
PDF pharmacodynamic effect and effects on liver function -Initiating Phase 1b proof-of-concept trial in severe alcohol-associated hepatitis - Expect to Present Safety, PD an [Read more]